Gamimune N 10% Interactions
There are 105 drugs known to interact with Gamimune N 10% (immune globulin intravenous), along with 3 disease interactions. Of the total drug interactions, 85 are major, 19 are moderate, and 1 is minor.
- View all 105 medications that may interact with Gamimune N 10%
- View Gamimune N 10% disease interactions (3)
Most frequently checked interactions
View interaction reports for Gamimune N 10% (immune globulin intravenous) and the medicines listed below.
- Actemra (tocilizumab)
- Adalat (nifedipine)
- Adasuve (loxapine)
- adenovirus vaccine
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Afinitor Disperz (everolimus)
- Atarax (hydroxyzine)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- Azilect (rasagiline)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Barhemsys (amisulpride)
- Beovu (brolucizumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Blincyto (blinatumomab)
- Brevibloc (esmolol)
- Buphenyl (sodium phenylbutyrate)
- calcium phosphate, tribasic
- Caplyta (lumateperone)
- Carbaglu (carglumic acid)
- Cardizem CD (diltiazem)
- Catapres-TTS (clonidine)
- Cayston (aztreonam)
- celecoxib
- Celestone (betamethasone)
- CellCept (mycophenolate mofetil)
- Cerubidine (daunorubicin)
- Cosmegen (dactinomycin)
- Oncovin (vincristine)
Gamimune N 10% disease interactions
There are 3 disease interactions with Gamimune N 10% (immune globulin intravenous) which include:
Report options
QR code containing a link to this page
More about Gamimune N 10% (immune globulin intravenous)
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.